Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel
you are here: HomeNewsIndia
Last Updated : Mar 27, 2020 12:07 PM IST | Source: Moneycontrol.com

Coronavirus lockdown: Collection suspended at all toll plazas across India

In a series of tweets, roads minister Nitin Gadkari said, "In view of Covid-19, it has been ordered to temporarily suspend the collection of toll at all toll plaza across India. This will not only reduce inconvenience to the supply of emergency services but also save critical time."

File image: Union Minister Nitin Gadkari
File image: Union Minister Nitin Gadkari

The collection of toll at all toll plazas across India has been temporarily suspended, Union Minister of Road Transport & Highways Nitin Gadkari informed through Twitter.

In a series of tweets, Gadkari said that the move would “reduce inconvenience to the supply of emergency services” and also “save critical time”.

Coronavirus India LIVE Updates

This tweet comes after the National Highway Authority of India (NHAI) has asked the road transport and highways ministry whether it should continue with collecting toll after a sharp drop in traffic triggered by the outbreak of the coronavirus, people familiar with the matter earlier told Moneycontrol.


Also Read: India likely to unveil $20 billion-plus stimulus package to tackle coronavirus downturn

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
According to NHAI data, toll collections through the electronic payment system FASTags, which account for 70 percent of the total collections, dropped by 50 percent in the past week. The total number of toll transactions also reduced by more than half.
First Published on Mar 26, 2020 08:21 am